Haemonetics Corporation (HAE) Financial Statements (2025 and earlier)

Company Profile

Business Address 125 SUMMER STREET
BOSTON, MA 02110
State of Incorp. MA
Fiscal Year End March 31
Industry (SIC) 3841 - Surgical and Medical Instruments and Apparatus (benchmarking)
More info Complete Financial Analysis Financial Benchmarking

Balance Sheet (Statement of Financial Position) ($ in thousands)

9/30/2024
MRQ
3/31/2024
12/31/2023
MRQ
3/31/2023
3/31/2022
3/31/2021
3/31/2020
ASSETS
Current Assets
Cash, cash equivalents, and short-term investments178,800193,978284,466259,496192,305137,311
Cash and cash equivalents178,800193,978284,466259,496192,305137,311
Receivables206,562211,611179,142159,376127,555165,207
Inventory, net of allowances, customer advances and progress billings317,202304,024259,379293,027322,614270,276
Inventory317,202304,024259,379293,027322,614270,276
Other undisclosed current assets66,33955,36946,73544,13251,07230,845
Total current assets:768,903764,982769,722756,031693,546603,639
Noncurrent Assets
Property, plant and equipment311,362318,665310,885258,482217,559253,399
Intangible assets, net (including goodwill)971,199984,269742,002777,548831,927343,758
Goodwill565,082554,999466,231467,287466,444210,652
Intangible assets, net (excluding goodwill)406,117429,270275,771310,261365,483133,106
Deferred income tax assets7,7395,0705,2414,4686,0093,930
Other noncurrent assets136,388127,442106,97563,20570,88262,384
Total noncurrent assets:1,426,6881,435,4461,165,1031,103,7031,126,377663,471
TOTAL ASSETS:2,195,5912,200,4281,934,8251,859,7341,819,9231,267,110
LIABILITIES AND EQUITY
Liabilities
Current Liabilities
Accounts payable and accrued liabilities154,066115,607128,404106,91197,893100,201
Employee-related liabilities64,47548,54047,60049,471
Accounts payable73,35856,84563,92958,37150,29350,730
Accrued liabilities80,70858,762    
Debt10,22913,73611,784214,14817,01676,980
Other liabilities136,088132,412111,628121,207138,58697,641
Total current liabilities:300,383261,755251,816442,266253,495274,822
Noncurrent Liabilities
Long-term debt and lease obligation797,564856,849754,102559,441690,592305,513
Long-term debt, excluding current maturities797,564856,849754,102559,441690,592305,513
Liabilities, other than long-term debt137,685138,505110,910108,603144,16699,666
Deferred income tax liabilities62,64462,24636,19528,72743,82510,562
Other liabilities75,04176,25974,71579,876100,34189,104
Total noncurrent liabilities:935,249995,354865,012668,044834,758405,179
Total liabilities:1,235,6321,257,1091,116,8281,110,3101,088,253680,001
Equity
Equity, attributable to parent959,959943,319817,997749,424731,670587,109
Common stock508508504511509503
Additional paid in capital634,627627,094594,706572,476602,727553,229
Accumulated other comprehensive loss(35,632)(24,382)(30,381)(25,954)(29,547)(45,135)
Retained earnings360,456340,099253,168202,391157,98178,512
Total equity:959,959943,319817,997749,424731,670587,109
TOTAL LIABILITIES AND EQUITY:2,195,5912,200,4281,934,8251,859,7341,819,9231,267,110

Income Statement (P&L) ($ in thousands)

9/30/2024
TTM
3/31/2024
12/31/2023
TTM
3/31/2023
3/31/2022
3/31/2021
3/31/2020
Revenues1,309,0551,406,2311,168,660993,196870,463988,479
Cost of revenue
(Cost of Goods and Services Sold)
(617,507)(644,683)(553,563)(487,694)(472,625)(503,966)
Gross profit:691,548761,548615,097505,502397,838484,513
Operating expenses(526,665)(532,126)(459,064)(424,752)(308,091)(381,162)
Operating income:164,883229,422156,03380,75089,747103,351
Nonoperating expense
(Other Nonoperating expense)
(13,018)(7,870)(14,630)(17,121)(16,834)(16,199)
Interest and debt expense(19,500) (13,000)(5,800)(9,400)(13,500)
Other undisclosed income (loss) from continuing operations before equity method investments, income taxes (13,000)  9,40013,500
Income from continuing operations before equity method investments, income taxes:132,365208,552128,40357,82972,91387,152
Other undisclosed income from continuing operations before income taxes19,50013,00013,0005,800  
Income from continuing operations before income taxes:151,865221,552141,40363,62972,91387,152
Income tax expense (benefit)(34,307)(42,594)(26,002)(20,254)6,556(10,626)
Income from continuing operations:117,558178,958115,40143,37579,46976,526
Income before gain (loss) on sale of properties:43,37579,46976,526
Net income available to common stockholders, diluted:117,558178,958115,40143,37579,46976,526

Comprehensive Income ($ in thousands)

9/30/2024
TTM
3/31/2024
12/31/2023
TTM
3/31/2023
3/31/2022
3/31/2021
3/31/2020
Net income:117,558178,958115,40143,37579,46976,526
Other comprehensive income (loss)(5,251)1,374(4,427)3,59315,588(14,755)
Comprehensive income, net of tax, attributable to parent:112,307180,332110,97446,96895,05761,771

Statements Sources

The financial statements are based on the Company's filings with the U.S. Securities and Exchange Commission (SEC) through the Electronic Data Gathering, Analysis, and Retrieval system (EDGAR). The information is derived from the 10-K and 10-Q reports submitted to the SEC in XBRL (eXtensible Business Reporting Language) format and presented according to the US GAAP Taxonomy. Please review the original filings for a more detailed information.

Login to ReadyRatios

 

Have you forgotten your password?

Are you a new user?

Login As
You can log in if you are registered at one of these services: